Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nkarta Inc
(NQ:
NKTX
)
6.530
-0.200 (-2.97%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nkarta Inc
< Previous
1
2
3
4
5
Next >
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2022
July 28, 2022
Via
Benzinga
SVB Leerink Picks This Well-Positioned NK Cell-Focused Stock, Sees 117% Upside
July 18, 2022
Via
Benzinga
Will Another Enlivex Innovation Break The Glass Ceiling For Solid Tumor Treatments?
June 14, 2022
Cell therapy — the use of stem cells and various engineered immune cells to target difficult-to-treat diseases like cancer and autoimmune conditions — has arguably been one of the big breakthroughs in...
Via
Benzinga
Expert Ratings for Nkarta
April 26, 2022
Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter:
Via
Benzinga
Investors Cheer Nkarta's First NK Cell Data With Multiple Complete Responses
April 25, 2022
Via
Benzinga
Positive Clinical Results Put Nkarta Stock on the Fast Track
May 09, 2022
NKTX stock is a fast mover, and a recent share-price bump came in the wake of exciting data from a "killer cell" anti-cancer research program.
Via
InvestorPlace
Executives Buy More Than $32M Of 3 Stocks
May 02, 2022
Although US stocks closed sharply lower on Friday, there were a few notable insider trades.
Via
Benzinga
How Is The Market Feeling About Nkarta Inc. - Common Stock?
April 27, 2022
Nkarta Inc. - Common Stock's (NASDAQ:NKTX) short percent of float has risen 8.05% since its last report. The company recently reported that it has 1.84 million shares sold short,...
Via
Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
April 26, 2022
Gainers Avadel Pharmaceuticals plc. (NASDAQ: AVDL) shares gained 36.3% to $5.74. Shares closed down 36% on Monday, seemingly on no news. Avadel issued a press release Tuesday...
Via
Benzinga
71 Biggest Movers From Yesterday
April 27, 2022
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...
Via
Benzinga
Futures Slide Ahead Of Tech Earnings Deluge
April 26, 2022
Markets in general are preoccupied by the prospect of tighter monetary policy conditions from global central banks to stem rising prices.
Via
Talk Markets
The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag For Vascular Biogenics Ovarian Cancer Gene Therapy
April 26, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 26, 2022
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
April 26, 2022
HC Wainwright & Co. raised Nkarta, Inc. (NASDAQ: NKTX) price target from $25 to $36. Nkarta shares fell 7.2% to $17.38 in pre-market trading.
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Eliem Therapeutics Shares Slide
April 25, 2022
U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite gaining around 70 points on Monday.
Via
Benzinga
60 Biggest Movers From Yesterday
April 26, 2022
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 25, 2022
Via
Benzinga
Mid-Day Market Update: Crude Oil Tumbles Over 6%; Nkarta Shares Spike Higher
April 25, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 400 points on Monday.
Via
Benzinga
34 Stocks Moving In Monday's Mid-Day Session
April 25, 2022
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen...
Via
Benzinga
Why Is Nkarta (NKTX) Stock Soaring 90% Today?
April 25, 2022
Nkarta (NKTX) stock is rocketing higher on Monday after the company released preliminary data from a Phase 1 clinical trial.
Via
InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Dow Tumbles Over 300 Points
April 25, 2022
U.S. stocks opened lower this morning, with the Dow Jones dropping more than 300 points on Monday.
Via
Benzinga
Benzinga's Daily Brief On Trending Tickers For April 25, 2022: Twitter, Coca-Cola, Nkarta, And More
April 25, 2022
Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items...
Via
Benzinga
How Nkarta Stock Scored A 90% Surge On Its 'Natural Killers' In Cancer
April 25, 2022
The biotech reported promising results for cell therapies without extreme side effects.
Via
Investor's Business Daily
Why Nkarta Stock Is Soaring Today
April 25, 2022
Nkarta Inc (NASDAQ: NKTX) shares are trading higher Monday morning after the company announced positive preliminary Phase 1 data from independent dose finding studies. The...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 25, 2022
Via
Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
April 24, 2022
Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...
Via
Benzinga
43 Stocks Moving In Tuesday's Mid-Day Session
March 22, 2022
Gainers Forge Global Holdings Inc. (NYSE: FRGE) shares jumped 67.7% to $16.95. True Global Ventures’ portfolio company Forge Global Holdings completed its business...
Via
Benzinga
35 Biggest Movers From Friday
October 11, 2021
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for...
Via
Benzinga
Exposures
Product Safety
61 Biggest Movers From Yesterday
December 02, 2021
Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.